Literature DB >> 9862852

Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells.

A Masumoto1, S Arao, M Otsuki.   

Abstract

To investigate the role of integrins in hepatocellular carcinoma (HCC) invasion, we analyzed the relationship between the expression and activity of beta1 integrins and the invasive ability of multiple HCC cell lines. Human HCC cell lines, PLC/PRF/5, Hep3B, HepG2, HLE, HuH7, and C3A cells, had high expression of beta1 and alpha6 subunits, and various levels of alpha1, alpha2, alpha3, and alpha5 expression as determined by cell surface flow cytometry. Activity of beta1 integrins was evaluated by cell adhesion to collagen, fibronectin, and laminin in the presence or absence of the stimulatory anti-beta1 monoclonal antibody (mAb) TS2/16. Different types of HCC cells showed various levels of constitutive activity of beta1 integrins as assessed by the TS2/16 requirement in cell adhesion. TS2/16 rapidly stimulated constitutively inactive or partially active beta1 integrins to fully active states, and as the result, the levels of cell adhesion to each ligand correlated with the expression levels of corresponding beta1 integrins. Thus, in the presence of TS2/16 stimulation, the levels of cell adhesion to collagen, fibronectin, and laminin correlated predominantly with the expression levels of alpha2, alpha5, and alpha6, respectively. Remarkably, as a result of in vitro chemoinvasion assay, the levels of constitutive activity of beta1 integrins correlated with the invasive ability of HCC cells. The inhibitory anti-beta1 mAb 13 almost completely blocked the invasion of PLC/PRF/5 and Hep3B cells that are the most invasive HCC cell lines. Alternatively, the stimulatory anti-beta1 mAb TS2/16 strongly inhibited the invasion. These results not only show an essential role of beta1 integrins in invasion of HCC cells but also suggest subtle regulatory mechanisms of cell invasion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9862852     DOI: 10.1002/hep.510290146

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  Integrin gene expression profiles of human hepatocellular carcinoma.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Zhi-Hua Liu; Jing Zhou; Wei-Hui Zhang; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 2.  Role of cell adhesion molecules in leukocyte recruitment in the liver and gut.

Authors:  A Ala; A P Dhillon; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2003-02       Impact factor: 1.925

3.  A novel LZAP-binding protein, NLBP, inhibits cell invasion.

Authors:  Junhye Kwon; Hyun Jung Cho; Seung Hun Han; Jin Gu No; Jae Young Kwon; Hongtae Kim
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

Review 4.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

5.  Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE.

Authors:  Makoto Nakamuta; Kazuhiro Kotoh; Munechika Enjoji; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

6.  Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.

Authors:  So-Hyun Shin; Kwang Ho Lee; Baek-Hee Kim; Sun Lee; Hwan Seok Lee; Ja-June Jang; Gyeong Hoon Kang
Journal:  Lab Invest       Date:  2014-10-13       Impact factor: 5.662

7.  Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.

Authors:  Pinar Kanlikilicer; Mohammed H Rashed; Recep Bayraktar; Rahul Mitra; Cristina Ivan; Burcu Aslan; Xinna Zhang; Justyna Filant; Andreia M Silva; Cristian Rodriguez-Aguayo; Emine Bayraktar; Martin Pichler; Bulent Ozpolat; George A Calin; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Cancer Res       Date:  2016-10-14       Impact factor: 12.701

8.  Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.

Authors:  Hua-Xing Ma; Qing-Hua Shu; Jing-Jing Pan; Dong Liu; Ge-Liang Xu; Jian-Sheng Li; Jin-Liang Ma; Wei-Dong Jia; Ji-Hai Yv; Yong-Sheng Ge
Journal:  Tumour Biol       Date:  2015-01-16

9.  S-phase delay in human hepatocellular carcinoma cells induced by overexpression of integrin beta1.

Authors:  Yu-Long Liang; Ting-Wen Lei; Heng Wu; Jian-Min Su; Li-Ying Wang; Qun-Ying Lei; Xi-Liang Zha
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy.

Authors:  Grant A Howe; Christina L Addison
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.